AR085649A1 - Derivados espirociclicos de isoxazolina como agentes antiparasitarios - Google Patents

Derivados espirociclicos de isoxazolina como agentes antiparasitarios

Info

Publication number
AR085649A1
AR085649A1 ARP120100780A ARP120100780A AR085649A1 AR 085649 A1 AR085649 A1 AR 085649A1 AR P120100780 A ARP120100780 A AR P120100780A AR P120100780 A ARP120100780 A AR P120100780A AR 085649 A1 AR085649 A1 AR 085649A1
Authority
AR
Argentina
Prior art keywords
alkyl
cyano
halo
haloalkyl
alkoxy
Prior art date
Application number
ARP120100780A
Other languages
English (en)
Inventor
Nathan Anthony Logan Chubb
Valerie A Vaillancourt
Sean Dw Greenwood
Timothy Stuk
Sanjay Menon
Denis Billen
Michael Curtis
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of AR085649A1 publication Critical patent/AR085649A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • C07D491/107Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N53/00Biocides, pest repellants or attractants, or plant growth regulators containing cyclopropane carboxylic acids or derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • A61K31/422Oxazoles not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/14Ectoparasiticides, e.g. scabicides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Environmental Sciences (AREA)
  • Dentistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Public Health (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

Reivindicación 1: Un compuesto caracterizado por la fórmula (1) o fórmula (2), en las que cada uno de Y y Z es independientemente C o N; cada uno de W1, W2 y W3 es independientemente C o N; V es C, N, O, o S; A, tomado junto con Y y Z o V, Y y Z es un anillo heterocíclico o carbocíclico, parcialmente saturado o saturado, de 5 a 7 miembros, en el que el que el anillo heterocíclico contiene al menos 1 a 3 heteroátomos seleccionados entre N, O ó S, y en el que el anillo A está opcionalmente sustituido con al menos un sustituyente seleccionado entre oxo, =S, =NR7, halo, hidroxilo, ciano, alquilo C1-6, haloalquilo C1-6 y alcoxi C1-6; cada uno de R1a, R1b y R1c es independientemente hidrógeno, halo, hidroxilo, ciano, nitro, alquilo C1-6, haloalquilo C1-6, alcoxi C1-6, alquil C0-3-cicloalquilo C3-6, haloalcoxi C1-6, -C(O)NH2, -SF5 o -S(O)pR; R2 es halo, ciano, alquilo C1-6, haloalquilo C1-6, nitro, hidroxilo, C(O)NRaRb, alquenilo C2-6, alquinilo C2-6, -S(O)pR o -OR; R3 es ciano, alquilo C1-6, haloalquilo C1-6, C(O)NRaRb, alquenilo C2-6, alquinilo C2-6, haloalquenilo C2-6 o haloalquinilo C2-6; R4 es hidrógeno, alquilo C1-6, alquil C0-6-cicloalquilo C3-6, -C(O)R5, -C(S)R5, C(O)NRaR5, C(O)C(O)NRaR5, -S(O)pRc, S(O)2NRaR5, -C(NR7)R5, C(NR7)NRaR5, alquilfenilo C0-6, alquilheteroarilo C0-6 o alquilheterociclo C0-6; R5 es hidrógeno, alquilo C1-6, alquenilo C2-6, alquil C0-6-cicloalquilo C3-6, alquilfenilo C0-6, alquilheteroarilo C0-6 o alquilheterociclo C0-6; R6 es hidrógeno, alquilo C1-6, hidroxilo o alcoxi C1-6; R7 es hidrógeno, alquilo C1-6, hidroxilo, ciano, nitro, S(O)pRc o alcoxi C1-6; R es alquilo C1-6 o cicloalquilo C3-6 opcionalmente sustituido con al menos un sustituyente halo; Ra es hidrógeno, alquilo C1-6 o alquil C0-3-cicloalquilo C3-6; en el que el alquilo y alquilcicloalquilo están opcionalmente sustituidos con ciano o al menos un sustituyente halo; Rb es hidrógeno, alquilo C1-6, cicloalquilo C3-8, alquilfenilo C0-3, alquilheteroarilo C0-3 o alquilheterociclo C0-3, cada uno opcionalmente sustituido, cuando sea químicamente posible, con al menos un sustituyente seleccionado entre hidroxilo, ciano, halo o -S(O)pR; Rc es alquilo C1-6, haloalquilo C1-6, haloalquil C1-6-cicloalquilo C3-6, alquil C0-3-cicloalquilo C3-6, alquilfenilo C0-3, alquilheteroarilo C0-3 o alquilheterociclo C0-3, cada uno opcionalmente sustituido con al menos un sustituyente seleccionado entre ciano, halo, hidroxilo, oxo, alcoxi C1-6, haloalcoxi C1-6, haloalquilo C1-6, S(O)pR, -SH, -S(O)pNRaRb, -NRaRb, -NRaC(O)Rb, -SC(O)R, -SCN o_C(O)NRaRb; cada uno de los restos alquilo C1-6 o alquil C0-6-cicloalquilo C3-6 de R4 y R5 puede estar opcional e independientemente sustituido con al menos un sustituyente seleccionado entre ciano, halo, hidroxilo, oxo, alcoxi C1-6, haloalcoxi C1-6, haloalquilo C1-6, alquilo C1-6, hidroxilalquil C1-6-, -S(O)pRc, -SH, -S(O)pNRaRb, -NRaRb, -NRaC(O)Rb, -SC(O)R, -SCN o -C(O)NRaRb; y en el que cada uno de los restos alquilfenilo C0-6, alquilheteroarilo C0-6, o alquilheterociclo C0-6 de R4 y R5 puede estar opcionalmente sustituido adicionalmente con al menos un sustituyente seleccionado entre ciano, halo, oxo, =S, =NR7, hidroxilo, alcoxi C1-6, hidroxilalquil C1-6-, alquilo C1-6, haloalquilo C1-6, -SH, -S(O)pR y haloalcoxi C1-6; n es el número entero 0, 1 ó 2, y cuando n es 2, cada R2 puede ser igual o diferente de cada uno de los demás; p es el número entero 0, 1 ó 2; y - - - - - es un enlace simple o doble; estereoisómeros del mismo y sales veterinariamente aceptables del mismo.Reivindicación 2: Una composición farmacéutica o veterinaria caracterizada porque comprende una cantidad terapéuticamente eficaz de un compuesto de fórmula (1) o fórmula (2) de la reivindicación 1.
ARP120100780A 2011-03-10 2012-03-09 Derivados espirociclicos de isoxazolina como agentes antiparasitarios AR085649A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161451256P 2011-03-10 2011-03-10
US201161489913P 2011-05-25 2011-05-25
US201161490804P 2011-05-27 2011-05-27

Publications (1)

Publication Number Publication Date
AR085649A1 true AR085649A1 (es) 2013-10-16

Family

ID=45852624

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP120100780A AR085649A1 (es) 2011-03-10 2012-03-09 Derivados espirociclicos de isoxazolina como agentes antiparasitarios

Country Status (26)

Country Link
US (1) US8466115B2 (es)
EP (1) EP2683723B1 (es)
JP (1) JP5806743B2 (es)
KR (1) KR101565853B1 (es)
CN (1) CN103517907B (es)
AR (1) AR085649A1 (es)
AU (1) AU2012226475C1 (es)
BR (1) BR112013023068B8 (es)
CA (1) CA2828397C (es)
CL (1) CL2013002516A1 (es)
CO (1) CO6761337A2 (es)
CY (1) CY1117987T1 (es)
ES (1) ES2585555T3 (es)
HK (1) HK1190393A1 (es)
HR (1) HRP20160601T1 (es)
HU (1) HUE029810T2 (es)
ME (1) ME02412B (es)
MX (1) MX2013010336A (es)
PL (1) PL2683723T3 (es)
PT (1) PT2683723T (es)
RS (1) RS54860B1 (es)
RU (1) RU2566083C3 (es)
SI (1) SI2683723T1 (es)
UY (1) UY33943A (es)
WO (1) WO2012120399A1 (es)
ZA (1) ZA201306817B (es)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3216448B8 (en) 2012-02-06 2019-06-05 Boehringer Ingelheim Animal Health USA Inc. Parasiticidal oral veterinary compositions comprising systemically-acting active agents, methods and uses thereof
JO3626B1 (ar) 2012-02-23 2020-08-27 Merial Inc تركيبات موضعية تحتوي على فيبرونيل و بيرميثرين و طرق استخدامها
RS57284B1 (sr) * 2012-08-31 2018-08-31 Zoetis Services Llc Kristalne forme 1-(5’-(5-(3,5-dihlor-4-fluorfenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3’h-spiro[azetidin-3,1’-izobenzofuran]-1-il)-2-(metilsulfonil)etanona
CA2882199A1 (en) 2012-09-04 2014-03-13 Zoetis Llc Spirocyclic isoxazoline derivatives for treatment of sea lice
WO2014039484A1 (en) * 2012-09-07 2014-03-13 Zoetis Llc Spirocyclic isoxazolines as antiparasitic agents
CA2881844A1 (en) * 2012-09-07 2014-03-13 Zoetis Llc Spirocyclic derivatives as antiparasitic agents
HUE045577T2 (hu) * 2012-09-07 2020-01-28 Zoetis Services Llc Spirociklusos izoxazolint tartalmazó parazitaellenes kombinációk
CA2892344C (en) 2012-11-21 2017-06-06 Zoetis Services Llc Synthesis of spirocyclic isoxazoline derivatives
SI2953942T1 (en) 2013-02-06 2018-03-30 Bayer Cropscience Ag Halogen-substituted pyrazole derivatives such as pesticides
WO2014189837A1 (en) * 2013-05-20 2014-11-27 Zoetis Llc Long-acting spiro-isoxazoline antiparasitic compositions
WO2015048371A1 (en) 2013-09-30 2015-04-02 Zoetis Llc Long-acting spiro-isoxazoline formulations
US9371293B2 (en) 2013-10-25 2016-06-21 Sumitomo Chemical Company, Limited Isoxazoline compound composition
CN105873925B (zh) 2013-11-01 2019-09-10 勃林格殷格翰动物保健美国公司 抗寄生物的和杀虫的异噁唑啉化合物
HUE066811T2 (hu) 2013-12-20 2024-09-28 Intervet Int Bv Izoxazolin kompozíciók és azok felhasználása parazitafertõzések megelõzésében és kezelésében állatokban
EP3089972B1 (de) 2014-01-03 2018-05-16 Bayer Animal Health GmbH Neue pyrazolyl-heteroarylamide als schädlingsbekämpfungsmittel
ES2765405T3 (es) 2014-04-17 2020-06-09 Boehringer Ingelheim Animal Health Usa Inc Utilización de compuestos de malononitrilo para proteger animales de parásitos
CA2955153A1 (en) 2014-07-15 2016-01-21 Bayer Animal Health Gmbh Aryl-triazolyl pyridines as pest control agents
AU2015339096B2 (en) 2014-10-31 2018-08-02 Boehringer Ingelheim Animal Health USA Inc. Parasiticidal composition comprising fipronil
EP3236960A1 (en) * 2014-12-22 2017-11-01 Intervet International B.V. Use of isoxazoline compounds for treating demodicosis
BR112017015137A2 (pt) * 2015-01-16 2018-01-30 Avista Pharma Solutions, Inc. compostos antiparasíticos
UY36570A (es) 2015-02-26 2016-10-31 Merial Inc Formulaciones inyectables de acción prolongada que comprenden un agente activo isoxazolina, métodos y usos de las mismas
KR102593069B1 (ko) 2015-04-08 2023-10-23 뵈링거 잉겔하임 애니멀 헬스 유에스에이 인코포레이티드 이속사졸린 활성제를 포함하는 서방형 주사 제형, 이의 방법 및 용도
ES2916216T3 (es) 2015-05-20 2022-06-29 Boehringer Ingelheim Animal Health Usa Inc Compuestos de depsipéptidos antihelmínticos
UY37137A (es) 2016-02-24 2017-09-29 Merial Inc Compuestos antiparasitarios de isoxazolina, formulaciones inyectables de acción prolongada que los comprenden, métodos y usos de los mismos
US20190077809A1 (en) 2016-03-09 2019-03-14 Basf Se Spirocyclic Derivatives
BR112018068042A2 (pt) * 2016-03-11 2019-01-08 Basf Se métodos para controlar pragas de plantas, material de propagação de planta e uso de um ou mais compostos de fórmula i
MX2020013754A (es) 2016-04-06 2022-07-25 Boehringer Ingelheim Animal Health Usa Inc Proceso para preparar compuestos de isoxazolina.
WO2017201134A1 (en) * 2016-05-20 2017-11-23 Avista Pharma Solutions, Inc. Synthetic process and novel intermediates
WO2018009751A1 (en) * 2016-07-08 2018-01-11 Avista Pharma Solutions, Inc. Antiparasitic compounds
WO2018039508A1 (en) 2016-08-25 2018-03-01 Merial, Inc. Method for reducing unwanted effects in parasiticidal treatments
AU2017344097A1 (en) 2016-10-14 2019-05-02 Boehringer Ingelheim Animal Health USA Inc. Pesticidal and parasiticidal vinyl isoxazoline compounds
EP3541789A1 (en) 2016-11-16 2019-09-25 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic depsipeptide compounds
WO2018162312A1 (en) * 2017-03-10 2018-09-13 Basf Se Spirocyclic derivatives
WO2018166855A1 (en) 2017-03-16 2018-09-20 Basf Se Heterobicyclic substituted dihydroisoxazoles
JP2020530850A (ja) * 2017-08-14 2020-10-29 ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド 殺有害生物および殺寄生生物ピラゾール−イソキサゾリン化合物
MX2020002496A (es) 2017-09-06 2020-07-20 Bayer Animal Health Gmbh Formulacion de uso topico para el control y la prevencion de parasitos en animales.
JP2021503465A (ja) * 2017-11-16 2021-02-12 アビスタ ファーマ ソリューションズ,インコーポレーテッド 単一エナンチオマーの抗寄生生物化合物
IL275339B2 (en) 2017-12-15 2024-03-01 Tarsus Pharmaceuticals Inc Parasitic formulations containing isoxazoline and methods for treating blepharitis
US11583545B2 (en) 2018-02-08 2023-02-21 Boehringer Ingelheim Animal Health USA Inc. Parasiticidal compositions comprising eprinomectin and praziquantel, methods and uses thereof
AU2019282274A1 (en) 2018-06-07 2021-01-28 Idorsia Pharmaceuticals Ltd Alkoxy-substituted pyridinyl derivatives as LPA1 receptor antagonists and their use in the treatment of fibrosis
EP3820870A1 (en) 2018-07-09 2021-05-19 Boehringer Ingelheim Animal Health USA Inc. Anthelminthic heterocyclic compounds
BR112021006053A2 (pt) 2018-10-29 2021-07-20 Basf Se processo de preparação de compostos, oximas z e compostos da fórmula vi
CN112969690A (zh) 2018-11-06 2021-06-15 巴斯夫欧洲公司 制备光学富集异噁唑啉类的方法
US11773066B2 (en) 2018-11-20 2023-10-03 Boehringer Ingelheim Animal Health USA Inc. Indazolylcyanoethylamino compound, compositions of same, method of making, and methods of using thereof
CA3120221A1 (en) 2018-12-04 2020-06-11 Basf Se Process for preparation of 5-bromo-1,3-dichloro-2-fluoro-benzene
WO2020150032A1 (en) 2019-01-16 2020-07-23 Boehringer Ingelheim Animal Health USA Inc. Topical compositions comprising a neonicotinoid and a macrocyclic lactone, methods and uses thereof
PE20220281A1 (es) 2019-03-19 2022-02-25 Boehringer Ingelheim Animal Health Usa Inc Compuestos de aza-benzotiofeno y aza-benzofurano como antihelminticos
AR119162A1 (es) 2019-06-18 2021-12-01 Idorsia Pharmaceuticals Ltd Derivados de piridin-3-ilo
BR112022012269A2 (pt) 2019-12-18 2022-08-30 Elanco Tiergesundheit Ag Derivados de isoxazolina como pesticidas
CN111253331B (zh) * 2020-03-17 2022-03-08 南京林业大学 一种以二氢查尔酮为原料合成螺异噁唑啉的方法
WO2021242481A1 (en) 2020-05-28 2021-12-02 Boehringer Ingelheim Animal Health USA Inc. Bi-modal release intra-ruminal capsule device and methods of use thereof
JP2023528822A (ja) 2020-05-29 2023-07-06 ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド 駆虫性複素環式化合物
CN111675668B (zh) * 2020-06-28 2022-09-13 南京林业大学 一种tempo催化的以肟类化合物为原料合成螺异噁唑啉的反应方法
US20220201983A1 (en) 2020-12-21 2022-06-30 Boehringer Ingelheim Animal Health USA Inc. Parasiticidal collar comprising isoxazoline compounds
US20240116854A1 (en) 2021-01-27 2024-04-11 Intervet Inc. Cyclopropylamide compounds against parasites in fish
US20240316045A1 (en) 2021-01-27 2024-09-26 Intervet Inc. Cyclopropylamide compounds against parasites in fish
JP2024516912A (ja) 2021-05-14 2024-04-17 シンジェンタ クロップ プロテクション アクチェンゲゼルシャフト 昆虫、ダニ目及び線虫有害生物の防除
EP4355735A1 (en) 2021-06-16 2024-04-24 Elanco Tiergesundheit AG Isoxazoline pesticides
WO2022263530A1 (en) 2021-06-16 2022-12-22 Elanco Tiergesundheit Ag (thi)oxazoline pesticides
WO2022268813A1 (en) 2021-06-24 2022-12-29 Syngenta Crop Protection Ag Insect, acarina and nematode pest control
WO2022268815A1 (en) 2021-06-24 2022-12-29 Syngenta Crop Protection Ag Insect, acarina and nematode pest control
WO2023046853A1 (en) 2021-09-23 2023-03-30 Syngenta Crop Protection Ag Insect, acarina and nematode pest control
US20230312207A1 (en) 2022-02-17 2023-10-05 Boehringer Ingelheim Vetmedica Gmbh Method and system for providing a fluid product mailer
WO2023203038A1 (en) 2022-04-19 2023-10-26 Syngenta Crop Protection Ag Insect, acarina and nematode pest control
FI20225388A1 (en) 2022-05-05 2023-11-06 Equinorm Ltd New heterocyclic compounds, preparation methods and their uses
DK202470076A1 (en) 2023-03-13 2024-10-10 Zoetis Services Llc Degradation of isoxazolines in ozonated sea water

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5554753A (en) 1993-08-25 1996-09-10 Indiana University Foundation Catalytic enantioselective synthesis of α-amino acid derivatives by phase-transfer catalysis
TW524667B (en) 1996-12-05 2003-03-21 Pfizer Parasiticidal pyrazoles
GB0329314D0 (en) 2003-12-18 2004-01-21 Pfizer Ltd Substituted arylpyrazoles
DK1731512T3 (en) * 2004-03-05 2015-01-05 Nissan Chemical Ind Ltd Isoxazoline-substituted benzamide AND INSTRUMENTS FOR COMBATING HARMFUL ORGANISMS
DK1904477T3 (da) 2005-07-14 2009-03-16 Hoffmann La Roche Indol-3-carbonyl-spiro-piperodom-derivater som V1A-receptorantagonister
TW200803740A (en) 2005-12-16 2008-01-16 Du Pont 5-aryl isoxazolines for controlling invertebrate pests
EP1997813B1 (en) 2006-03-10 2010-05-05 Nissan Chemical Industries, Ltd. Substituted isoxazoline compound and pest control agent
US8575167B2 (en) 2007-02-06 2013-11-05 Takeda Pharmaceutical Company Limited Spiro compounds having stearoyl-CoA desaturase action
MY146638A (en) 2007-04-10 2012-09-14 Bayer Cropscience Ag Insecticidal aryl isoxazoline derivatives
JP5184057B2 (ja) * 2007-08-10 2013-04-17 日本曹達株式会社 含窒素複素環化合物および有害生物防除剤
JP5365806B2 (ja) 2007-09-10 2013-12-11 日産化学工業株式会社 置換イソキサゾリン化合物及び有害生物防除剤
WO2009063910A1 (ja) 2007-11-12 2009-05-22 Nissan Chemical Industries, Ltd. 光学活性イソキサゾリン化合物の触媒的不斉合成方法
JP2009286773A (ja) * 2008-03-14 2009-12-10 Bayer Cropscience Ag 殺虫性縮環式アリール類
BRPI0918500A2 (pt) 2008-09-04 2015-09-22 Syngenta Participations Ag compostos inseticidas
JP5488835B2 (ja) * 2008-09-04 2014-05-14 日産化学工業株式会社 置換アセトフェノン化合物、その製造方法及び用途
EP2332927A4 (en) 2008-09-18 2012-07-18 Nippon Soda Co HETEROCYCLIC COMPOUND CONTAINING NITROGEN AND AGENT FOR CONTROLLING HARMFUL ANIMALS
BRPI1007310A2 (pt) * 2009-01-22 2015-08-25 Syngenta Participations Ag Compostos inseticidas.
MX2012009707A (es) 2010-02-25 2012-09-12 Syngenta Ltd Proceso para preparar derivados isoxazolinicos.

Also Published As

Publication number Publication date
RS54860B1 (sr) 2016-10-31
CO6761337A2 (es) 2013-09-30
ME02412B (me) 2016-09-20
AU2012226475B2 (en) 2015-04-30
WO2012120399A1 (en) 2012-09-13
NZ614547A (en) 2014-12-24
ES2585555T3 (es) 2016-10-06
PL2683723T3 (pl) 2017-07-31
HUE029810T2 (en) 2017-03-28
SI2683723T1 (sl) 2016-07-29
US20120232026A1 (en) 2012-09-13
UY33943A (es) 2012-10-31
MX2013010336A (es) 2013-10-03
CA2828397C (en) 2015-10-13
RU2566083C2 (ru) 2015-10-20
PT2683723T (pt) 2016-08-05
CA2828397A1 (en) 2012-09-13
BR112013023068A2 (pt) 2016-07-26
ZA201306817B (en) 2016-07-27
AU2012226475A1 (en) 2013-09-12
KR20140017590A (ko) 2014-02-11
JP2014508773A (ja) 2014-04-10
AU2012226475C1 (en) 2015-08-06
BR112013023068B8 (pt) 2022-11-22
EP2683723B1 (en) 2016-05-25
EP2683723A1 (en) 2014-01-15
HRP20160601T1 (hr) 2016-07-01
JP5806743B2 (ja) 2015-11-10
RU2013139630A (ru) 2015-04-20
BR112013023068B1 (pt) 2020-11-17
CN103517907B (zh) 2016-07-06
HK1190393A1 (zh) 2014-07-04
CY1117987T1 (el) 2017-05-17
US8466115B2 (en) 2013-06-18
RU2566083C3 (ru) 2017-11-09
CN103517907A (zh) 2014-01-15
CL2013002516A1 (es) 2014-06-13
KR101565853B1 (ko) 2015-11-05

Similar Documents

Publication Publication Date Title
AR085649A1 (es) Derivados espirociclicos de isoxazolina como agentes antiparasitarios
AR082562A1 (es) Derivados de isoxazolina como agentes antiparasitarios
AR083081A1 (es) Isoxazolin oximas como agentes antiparasitarios
CO6251271A2 (es) Derivados de pirimidina trisustituida para el tratamiento de enfermedades proliferativas
AR086474A1 (es) Compuestos de pirazol pesticidas
AR111813A2 (es) Compuestos y composiciones para el control de nematodos
AR072952A1 (es) Compuestos de 2-imino-3-metilpirrolopirimidinona fenilo-sustituida como inhibidores de bace-1, composiciones y su uso
PE20091972A1 (es) Compuestos heterociclicos como inhibidores del factor ixa
AR054560A1 (es) Espiropiperidina como inhibidores de beta-secretasa para el tratamiento de la enfermedad de alzheimer
CL2020001919A1 (es) Inhibidores de endonucleasa cap-dependientes.
GT200700036A (es) Compuestos fenil amido heterociclicos condensados
CO6260076A2 (es) Derivados de uracilo o timina para el tratamiento de la hepatitis c
PE20081836A1 (es) Derivados de piperidina como inhibidores de la sintasa de acido graso
AR064736A1 (es) Agonistas de gpcr
AR050540A1 (es) Derivados de adamantilamida triciclica como inhibidores de deshidrogenasa 11- beta hidroxiesteroide
AR060401A1 (es) Derivados de cromen-2-ona
AR062797A1 (es) Derivados de piperidina como inhibidores de renina, composiciones farmaceuticas.
AR056103A1 (es) Compuestos de(piran-piperidinil)benzimidazol, composiciones farmaceuticas que los comprenden, proceso de preparacion y usos en el tratamiento de afecciones mediadas por agonistas del receptor muscarinico m1
AR074648A1 (es) Derivados de isoxazolina que poseen un anillo de cuatro miembros como grupo terminal, intermediarios de sintesis, composiciones biocidas que los contienen y metodos para combatir y controlar dichas plagas
AR085354A1 (es) Derivados de isoxazol para control de pestes invertebrados
ES2570127T3 (es) Compuestos y composiciones como inhibidores de la proteína quinasa
AR076765A1 (es) Compuestos antivirales
AR075635A1 (es) N-alcoxiamidas de 6-(fenil sustituido)-4-aminopicolinatos y 2-(fenil sustituido)-6-amino-4-pirimidina carboxilatos, su uso como herbicidas selectivos para las cosechas y proceso de preparacion de dichos compuestos
PE20090601A1 (es) Derivados de piridin-il-oxi-piridinas como inhibidores de alk5
PE20142081A1 (es) Inhibidores de quinurenina-3-monooxigenasa, composiciones farmaceuticas y metodo de uso de los mismos

Legal Events

Date Code Title Description
FG Grant, registration